Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $378.6 million.

  • Maravai Lifesciences Holdings' Total Non-Current Liabilities fell 37.94% to $379.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.4 million, marking a year-over-year decrease of 37.94%. This contributed to the annual value of $378.6 million for FY2024, which is 40.67% down from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Total Non-Current Liabilities stood at $378.6 million, which was down 40.67% from $638.1 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Total Non-Current Liabilities high stood at $1.3 billion for FY2021, and its period low was $378.6 million during FY2024.
  • Its 3-year average for Total Non-Current Liabilities is $774.9 million, with a median of $638.1 million in 2023.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Total Non-Current Liabilities climbed by 19.59% in 2021 and then tumbled by 51.22% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Total Non-Current Liabilities stood at $1.1 billion in 2020, then rose by 19.59% to $1.3 billion in 2021, then decreased by 1.78% to $1.3 billion in 2022, then slumped by 51.22% to $638.1 million in 2023, then crashed by 40.67% to $378.6 million in 2024.